首页 | 本学科首页   官方微博 | 高级检索  
     

非小细胞肺癌中p16基因甲基化的临床分析
引用本文:徐乾乾,刘峰,王中林,钱永祥,张蕾,占向鸿,张洪涛,刘泽毅,雷哲,狄洪震. 非小细胞肺癌中p16基因甲基化的临床分析[J]. 中国血液流变学杂志, 2013, 0(4): 602-605
作者姓名:徐乾乾  刘峰  王中林  钱永祥  张蕾  占向鸿  张洪涛  刘泽毅  雷哲  狄洪震
作者单位:[1]常州市第一人民医院呼吸内科,江苏常州213003 [2]常州市第一人民医院心胸外科,江苏常州213003 [3]苏州大学癌症分子遗传学实验室,江苏苏州215123
摘    要:
目的:研究非小细胞肺癌中p16基因甲基化的表达,分析p16基因甲基化与临床、病理资料之间的相关性。方法对61例经手术切除且病理确诊的非小细胞肺癌在术中提取新鲜癌组织和癌旁组织样本冷冻保存,提取DNA后经重亚硫酸盐修饰,用甲基化特异性PCR(MSP)方法检测癌和癌旁组织中p16基因甲基化状态。结合临床及病理资料对实验结果进行统计学分析。结果非小细胞肺癌和癌旁组织中出现p16基因甲基化的阳性率分别为11.48%(7/61)和1.64%(1/61)(P>0.05)。不同的病理分型、分化程度、TNM分期、淋巴结转移程度及吸烟指数间p16基因甲基化状态差异无统计学意义(P>0.05)。结论非小细胞肺癌组织中存在p16基因甲基化。

关 键 词:非小细胞肺癌  p16基因  甲基化

Clinical Analysis of Methylation of p16 Gene in Non-small Cell Lung Cancer
XU Qian-qian,LIU Feng,WANG Zhong-lin,QIAN Yong-xiang,ZHANG Lei,ZHAN Xiang-hong,ZHANG Hong-tao,LIU Ze-yi,LEI Zhe,DI Hong-zhen. Clinical Analysis of Methylation of p16 Gene in Non-small Cell Lung Cancer[J]. Chinese Journal of Hemorheology, 2013, 0(4): 602-605
Authors:XU Qian-qian  LIU Feng  WANG Zhong-lin  QIAN Yong-xiang  ZHANG Lei  ZHAN Xiang-hong  ZHANG Hong-tao  LIU Ze-yi  LEI Zhe  DI Hong-zhen
Affiliation:1 .Respiratory Department, 2.Cardiothoracic Surgery Department, the First People's Hospital of Changzhou, Changzhou, Jiangsu, 213003, China; 3.Cancer Molecular Genetics Laboratory of Soochow University, Suzhou, Jiangsu, 215123, China)
Abstract:
Objective To investigate methylation of p16 gene in non-small cell lung cancer (NSCLC), and analyze the correlation between it and clinical and pathological data. Methods Specimens were taken from 61 NSCLC patients pathological conifrmed after surgical resection. Fresh tumor samples matched with corresponding adjacent normal tissue were taken during operation and frozen preserved. After extraction and Bisulifte treatment of DNA from the frozen tissues, we examined the methylation of p16 gene in NSCLC tissues and corresponding paracancerous tissues by using methylation-speciifc PCR (MSP) method. Then the result of experiment was ana-lyzed statistically combined with clinical and pathological data. Results The positive rate of the methylation of p16 gene was respectively 11.48%(7/61) in lung cancer tissues and 1.64%(1/61) in paracancerous tissues (P〉0.05). No signiifcant difference was found in the methylation of p16 gene according to different pathologic classi-ifcation, differentiation of cancer, TNM stage, the extent of metastasis of lymph node and smoking index (P〉0.05). Conclusion The methylation of p16 gene existed in NSCLC tissues.
Keywords:NSCLC  p16 gene  methylation
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号